【摘要】 <正> 体外佩带式起搏器作为永久性起搏器缺点甚多,因此,只适用于临时性起搏。目前体内埋藏式心脏起搏器已成为临床上永久性心脏起搏的主要方法。我院自1979年7月～1983年6月共装埋藏式心脏起搏器25例,因其中4例随访时间较短,兹仅报告21例如下: 一、临床资料本组共21例,男11例,女10例;年龄21～81岁,平均58.6岁,大于60岁11例。冠心病17例(合并高血压5例),病毒性心肌炎3例,心肌病1例。21例中18例为完全性房室传导阻滞合并复发性心脑缺血综合征,3例为病态窦房结综合征引起反复性昏厥。6例装国产埋藏式R抑制型按需起搏器(5例南京产品,1例复旦大学产品),14例是美国制埋藏式R抑制型按需起搏品(其中2例是多功能程序控制式心脏起搏器),1例是澳大利亚制多功能程序控制式心脏起搏器。插管途径、电极和起搏器的位置:经头静脉16例(右侧10例,左侧6例),3例因头静脉细小,插管困难,改用右颈外静脉,2例因更多还原

【Abstract】 The results of long-term follow-up of 21 patients with implanted cardiac pacemakers were analysed in this article. The average follow-up period is 3 years. Among them, cardiac pacing was kept well in 14 cases and pacing failure was found in 7 cases. The causes of pacing failure were: rupture of the pacing catheter in one case; a tear of the insulated layer of the pacing catheters for two cases, which resulted in premature failure of the batteries; dislocation of the pacing electrode in one case; rising of the threshold in one ease; serious local infection in two cases. Thus, the electrode of ths pacemaker was the key problem in monitoring the implanted cardiac pacemaker patients, so that the quality of carliac paemaker must be improved and well guaranteed.更多还原